Now live: Pro — the full 13F research suite for serious investorsSee pricing →
BFAM Partners (Cayman) Ltd

Q3 2024 · 13F-HR

BFAM Partners (Cayman) Ltdholdings as filed

Filed 2024-11-13 · accession 0001639101-24-000007

$44,000
Reported value
1
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G9845F117LSBWFLAKESHORE BIOPHARMA CO LTD$44,000100.0%550,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.